Consult
Log In
Menu
Consult
Log in

by PierianDx, on February 7, 2019

At PierianDx, we are well-versed in helping healthcare organizations implement clinical next generation sequencing (NGS) testing programs. But beyond implementation of genomic testing programs at individual institutions, what must happen to make this technology more readily available to all? 

Read Story
Topics:Blog

by PierianDx, on January 4, 2019

Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis

Read Story
Topics:News

by PierianDx, on October 24, 2018

Precision medicine is the ability to use genomic information to optimize diagnosis and treatment and provide better outcomes for patients. “We Know Precision Medicine” is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In honor of breast cancer awareness month, Bryce Daines, VP Product Development, discusses his role at PierianDx and why, as the spouse of a breast cancer survivor, precision medicine is so important to him.

Read Story
Topics:Blog

by PierianDx, on September 28, 2018

Join us October 31- November 3 at the Association for Molecular Pathology (AMP) annual meeting in San Antonio, Texas. Visit us any day of the conference in Booth 800. Also, plan to attend one of our workshops or in-booth presentations. 

Workshop 1

Supporting NGS-Based IVD Assays with the Most Accurate, Comprehensive and Clinically Robust Knowledgebase

Clinical NGS has been widely adopted as Laboratory Derived Tests (LDTs). NGS-based in vitro diagnostics (IVD) recently gained FDA approval with many others now in process. These IVD assays facilitate broad, widespread adoption of NGS-based testing globally in cancer and other complex conditions that require timely, accurate diagnoses and treatment. To support comprehensive interpretation of these assays, we have developed the PierianDx KnowledgeBase. Driven by the richest set of curated and rationalized content of medical interpretations, clinical practice guidelines, FDA therapeutics and clinical trials, the PierianDx KnowledgeBase offers the most well-vetted interpretations and classifications of genomic variants for IVD use.

October 31 @ 3:00 PM in RM 214D (Refreshments provided).

Add to Calendar

Workshop 2

Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

Broader adoption of next-generation sequencing-based cancer testing reveals the challenges associated with variant interpretation and underscores the need to standardize results across molecular pathology labs. In this informative workshop, we review the guidelines developed by the Association for Molecular Pathology (AMP) and describe how to put them into practice using real clinical cases.

October 31 @ 12:00 PM in RM 214D (boxed lunches provided for the first 50 to arrive).

Add to Calendar

 

Read Story
Topics:BlogUpcoming Conference

by PierianDx, on September 13, 2018

Precision medicine is the ability to use genomic information to optimize diagnosis and treatment and provide better outcomes for patients. We Know Precision Medicine is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In honor of childhood cancer awareness month, Lisa Owen, Marketing Director, discusses her role at PierianDx and why precision medicine is so important to her.

Read Story
Topics:Blog

by Michael L. Sanderson, on September 4, 2018

In many healthcare settings the important role of pathology is underestimated and misunderstood. Likely, we can thank TV crime shows for the public perception that pathologists only perform autopsies and complicated analyses that help catch bad guys.

Read Story
Topics:Blog

by PierianDx, on August 29, 2018

Are you considering offering clinical NGS testing or looking for an economical approach to building your program? 

Read Story
Topics:Blog

by PierianDx, on August 24, 2018

We Know Precision Medicine is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this article, Shalini Verma, Laboratory and Medical Director, discusses her role at PierianDx and how our products and services will help make precision medicine a routine component of healthcare.  

Read Story
Topics:Blog

by PierianDx, on August 14, 2018

Recently we hosted a webinar in which Medical Director, Shalini Verma, and VP Product, Andy Bredemeyer, reviewed and applied the Association for Molecular Pathology (AMP) joint consensus guidelines for the interpretation and reporting of sequence variants in cancer. 

Read Story
Topics:Blog

by Lisa Owen, on July 26, 2018

"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this article, Andy Bredemeyer, VP Product, discusses how PierianDx has given him the opportunity to impact patient care in a way he never thought possible. 

Read Story
Topics:Blog

by Lisa Owen, on July 13, 2018

Preparing for our upcoming webinar -- A Practice-based Guide for Interpretation and Reporting of Sequence Variants in Cancer--caused us to think about the evolution of next generation sequencing (NGS) into the clinic and how there’s hasn't been a dull moment since this technology was first introduced.

Read Story
Topics:Blog

by PierianDx, on June 27, 2018

"We Know Precision Medicine" is a series of blog posts and articles about the people of PierianDx and how we know precision medicine through our expertise and personal experiences. In this first article, Rakesh Nagarajan, Founder and Executive Chairman, discusses the origin of PierianDx and why he has devoted his life to make precision medicine a reality.

Read Story
Topics:Blog